Rubius Therapeutics, Inc. (RUBY) News
Filter RUBY News Items
RUBY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest RUBY News From Around the Web
Below are the latest news stories about RUBIUS THERAPEUTICS INC that investors may wish to consider to help them evaluate RUBY as an investment opportunity.
Why Is Atreca (BCEL) Stock Up Today?Atreca (BCEL) stock is getting a boost on Tuesday as the biopharmaceutical company continues a recent rally connected to insider buying. |
Why Is Rubius Therapeutics (RUBY) Stock Up 35% Today?Rubius Therapeutics (RUBY) stock is heading higher on Tuesday despite a lack of news from the cellular medicines company. |
Why Is T2 Biosystems (TTOO) Stock Down 21% Today?T2 Biosystems (TTOO) stock is falling hard on Tuesday as investors react to a proposed public offering from the company. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday! |
Blink Charging (BLNK) Stock Slumps on Public Offering NewsBlink Charging (BLNK) stock is sliding lower on Tuesday after revealing pricing and other details from its public offering. |
Why Is Kiora Pharmaceuticals (KPRX) Stock Up 61% Today?Kiora Pharmaceuticals (KPRX) stock is heading higher on Tuesday thanks to an update on its KIO-101 eye drops clinical trial. |
Why Is Rubius Therapeutics (RUBY) Stock Down 16% Today?Rubius Therapeutics (RUBY) stock is falling hard on Tuesday after the biotechnology company received a Nasdaq delisting notice. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayThe final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday! |
Former Rubius CEO jumps to another Flagship spinoutPablo Cagnoni, who was CEO of the soon-to-shutter Rubius Therapeutics Inc. until earlier this year, has joined another Flagship Pioneering-backed startup. |
Rubius Therapeutics lays off most of its staff, explores saleRubius Therapeutics is in the final days of its existence. The company is laying off 82% of its workforce and will begin looking at a sale or merger. |